Cipla | CIPLA - Sales Revenues

Stock Price
1,350.70
Daily Change
4.60 0.34%
Monthly
2.87%
Yearly
-6.28%
Q1 Forecast
1,315.62

Cipla reported INR75.18B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Capricor Therapeutics USD 0 11.13M Mar/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
Nektar Therapeutics USD 24.12M 635K Sep/2024
Sangamo BioSciences USD 356K 125K Jun/2024
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
TherapeuticsMD USD 234K 79K Jun/2024
UPL INR 123.61B 3.42B Dec/2025